18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Eomes hi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human liver contains an Eomes hi population of NK cells that is not present in the blood. In this study, we show that these cells are characterized by a molecular signature that mediates their retention in the liver. By examining liver transplants where donors and recipients are HLA mismatched, we distinguish between donor liver–derived and recipient-derived leukocytes to show that Eomes lo NK cells circulate freely whereas Eomes hi NK cells are unable to leave the liver. Furthermore, Eomes hi NK cells are retained in the liver for up to 13 y. Therefore, Eomes hi NK cells are long-lived liver-resident cells. We go on to show that Eomes hi NK cells can be recruited from the circulation during adult life and that circulating Eomes lo NK cells are able to upregulate Eomes and molecules mediating liver retention under cytokine conditions similar to those in the liver. This suggests that circulating NK cells are a precursor of their liver-resident counterparts.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology.

          Innate lymphoid cells (ILCs) are a growing family of immune cells that mirror the phenotypes and functions of T cells. However, in contrast to T cells, ILCs do not express acquired antigen receptors or undergo clonal selection and expansion when stimulated. Instead, ILCs react promptly to signals from infected or injured tissues and produce an array of secreted proteins termed cytokines that direct the developing immune response into one that is adapted to the original insult. The complex cross-talk between microenvironment, ILCs, and adaptive immunity remains to be fully deciphered. Only by understanding these complex regulatory networks can the power of ILCs be controlled or unleashed in order to regulate or enhance immune responses in disease prevention and therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

            Much has been learned about how cells enter lymphoid tissues. But how do they leave? Sphingosine-1-phosphate (S1P) has emerged over the past decade as a central mediator of lymphocyte egress. In this review, we summarize the current understanding of how S1P promotes exit from the secondary lymphoid organs and thymus. We review what is known about additional requirements for emigration and summarize the mostly distinct requirements for exit from the bone marrow. Egress from lymphoid organs is limited during immune responses, and we examine how this regulation works. There is accumulating evidence for roles of S1P in directing immune cell behavior within lymphoid tissues. How such actions can fit together with the egress-promoting role of S1P is discussed. Finally, we examine current understanding of how FTY720, a drug that targets S1P receptors and is approved for the treatment of multiple sclerosis, causes immune suppression.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success

              Preeclampsia is a serious complication of pregnancy in which the fetus receives an inadequate supply of blood due to failure of trophoblast invasion. There is evidence that the condition has an immunological basis. The only known polymorphic histocompatibility antigens on the fetal trophoblast are HLA-C molecules. We tested the idea that recognition of these molecules by killer immunoglobulin receptors (KIRs) on maternal decidual NK cells is a key factor in the development of preeclampsia. Striking differences were observed when these polymorphic ligand: receptor pairs were considered in combination. Mothers lacking most or all activating KIR (AA genotype) when the fetus possessed HLA-C belonging to the HLA-C2 group were at a greatly increased risk of preeclampsia. This was true even if the mother herself also had HLA-C2, indicating that neither nonself nor missing-self discrimination was operative. Thus, this interaction between maternal KIR and trophoblast appears not to have an immune function, but instead plays a physiological role related to placental development. Different human populations have a reciprocal relationship between AA frequency and HLA-C2 frequency, suggesting selection against this combination. In light of our findings, reproductive success may have been a factor in the evolution and maintenance of human HLA-C and KIR polymorphisms.
                Bookmark

                Author and article information

                Journal
                J Immunol
                J. Immunol
                jimmunol
                jimmunol
                JI
                The Journal of Immunology Author Choice
                AAI
                0022-1767
                1550-6606
                1 December 2016
                21 October 2016
                : 197
                : 11
                : 4283-4291
                Affiliations
                [* ]Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom; and
                []Department of Surgery and Interventional Science, University College London, Royal Free Hospital, London NW3 2QG, United Kingdom
                Author notes
                Address correspondence and reprint requests to Dr. Victoria Male, Institute of Immunity and Transplantation, University College London, London NW3 2PF, U.K. E-mail address: v.male@ 123456ucl.ac.uk
                Author information
                http://orcid.org/0000-0001-5016-5944
                http://orcid.org/0000-0002-4161-9462
                http://orcid.org/0000-0001-5654-5083
                Article
                ji_1601424
                10.4049/jimmunol.1601424
                5114885
                27798170
                50b0524f-66f2-4865-9d5c-4d31c8f8d98a
                Copyright © 2016 The Authors

                This is an open-access article distributed under the terms of the CC-BY 3.0 Unported license .

                History
                : 15 August 2016
                : 24 September 2016
                Page count
                Figures: 5, Equations: 0, References: 47, Pages: 9
                Categories
                Clinical and Human Immunology

                Comments

                Comment on this article